Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Operating Expenses (2019 - 2025)

Korro Bio's Operating Expenses history spans 7 years, with the latest figure at $51.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 104.21% year-over-year to $51.7 million, compared with a TTM value of $128.2 million through Dec 2025, up 36.17%, and an annual FY2025 reading of $128.2 million, up 36.17% over the prior year.
  • Operating Expenses for Q4 2025 was $51.7 million at Korro Bio, up from $20.3 million in the prior quarter.
  • The five-year high for Operating Expenses was $51.7 million in Q4 2025, with the low at -$5.8 million in Q4 2022.
  • Average Operating Expenses over 5 years is $23.2 million, with a median of $23.3 million recorded in 2022.
  • Year-over-year, Operating Expenses crashed 127.19% in 2022 and then soared 563.03% in 2023.
  • Tracing KRRO's Operating Expenses over 5 years: stood at $21.4 million in 2021, then plummeted by 127.19% to -$5.8 million in 2022, then soared by 563.03% to $26.9 million in 2023, then decreased by 5.88% to $25.3 million in 2024, then soared by 104.21% to $51.7 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Operating Expenses are $51.7 million (Q4 2025), $20.3 million (Q3 2025), and $28.7 million (Q2 2025).